What one share of Promis Neurosciences holds
ProMIS has in-licensed a patented technology platform with the potential to deliver a portfolio of antibody therapies, therapeutic vaccines, and other therapies derived from antibodies for neurodegenerative diseases and other misfolded protein diseases, which may include Alzheimer’s disease, multiple system atrophy, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, Parkinson’s disease, progressive supranuclear palsy, corticobasal degeneration (respectively…
Promis Neurosciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$8.50 |
|---|---|
| Cash and investments | $5.96 |
| Book value | $5.51 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | — | −$42.30 | $0.03 | −$40.24 | — | $19.67 |
| 2022 | — | −$60.19 | $0.01 | −$56.77 | — | −$3.93 |
| 2023 | — | −$26.87 | — | — | — | $4.97 |
| 2024 | — | $2.63 | — | — | — | $12.61 |
| 2025 | — | −$22.61 | — | — | — | −$0.58 |
Common questions about Promis Neurosciences
How much does one share of Promis Neurosciences earn?
Over the last 12 months, Promis Neurosciences lost $8.50 for each share.
Does Promis Neurosciences pay a dividend?
Promis Neurosciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Promis Neurosciences’s book value per share?
Promis Neurosciences’s book value is $5.51 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Promis Neurosciences have?
Each share of Promis Neurosciences has $5.96 of cash and investments, as of June 30, 2026.
Has Promis Neurosciences bought back shares?
Promis Neurosciences’s share count rose about 659% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.